Your browser doesn't support javascript.
loading
Characterization of monomeric and soluble aggregated Aß in Down's syndrome and Alzheimer's disease brains.
Gkanatsiou, Eleni; Sahlin, Charlotte; Portelius, Erik; Johannesson, Malin; Söderberg, Linda; Fälting, Johanna; Basun, Hans; Möller, Christer; Odergren, Tomas; Zetterberg, Henrik; Blennow, Kaj; Lannfelt, Lars; Brinkmalm, Gunnar.
Affiliation
  • Gkanatsiou E; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. Electronic address: eleni.gkanatsiou@gu.se.
  • Sahlin C; BioArctic AB, Stockholm, Sweden; Department of Public Health/Geriatrics, Uppsala University, Uppsala, Sweden.
  • Portelius E; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Johannesson M; BioArctic AB, Stockholm, Sweden.
  • Söderberg L; BioArctic AB, Stockholm, Sweden.
  • Fälting J; BioArctic AB, Stockholm, Sweden.
  • Basun H; BioArctic AB, Stockholm, Sweden.
  • Möller C; BioArctic AB, Stockholm, Sweden.
  • Odergren T; BioArctic AB, Stockholm, Sweden.
  • Zetterberg H; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, Unit
  • Blennow K; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Lannfelt L; BioArctic AB, Stockholm, Sweden; Department of Public Health/Geriatrics, Uppsala University, Uppsala, Sweden.
  • Brinkmalm G; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Neurosci Lett ; 754: 135894, 2021 05 29.
Article in En | MEDLINE | ID: mdl-33848613
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Brain / Amyloid beta-Peptides / Down Syndrome / Alzheimer Disease Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurosci Lett Year: 2021 Document type: Article Country of publication: Ireland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Brain / Amyloid beta-Peptides / Down Syndrome / Alzheimer Disease Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurosci Lett Year: 2021 Document type: Article Country of publication: Ireland